Lize D. Van Vulpen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Journal: The New England journal of medicine

Published: April 29, 2026

Long-term prosthesis survival of total hip and total knee arthroplasty in people with inherited bleeding disorders.

Long-term prosthesis survival of total hip and total knee arthroplasty in people with inherited bleeding disorders.

Journal: Research and practice in thrombosis and haemostasis

Published: February 26, 2026

Predicting Recovery After Joint Bleeding in Persons With Bleeding Disorders.

Predicting Recovery After Joint Bleeding in Persons With Bleeding Disorders.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: December 02, 2025

An 80-year-old man with a rare disease manifestation of disseminated cryptococcosis.

An 80-year-old man with a rare disease manifestation of disseminated cryptococcosis.

Journal: IDCases

Published: July 10, 2025

Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.

Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 05, 2025

Inhibitor Formation in the Era of Novel Haemophilia Treatment-A Humanized Mouse Model to Answer Our Questions?

Inhibitor Formation in the Era of Novel Haemophilia Treatment-A Humanized Mouse Model to Answer Our Questions?

Journal: Thrombosis and haemostasis

Published: March 06, 2025

No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy.

No correlation between thrombin generation and emicizumab levels: implications for monitoring emicizumab therapy.

Journal: Research and practice in thrombosis and haemostasis

Published: November 07, 2024

Letter in response to Bounaix et al. "Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature".

Letter in response to Bounaix et al. "Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature".

Journal: Research and practice in thrombosis and haemostasis

Published: June 28, 2024

A clinical practice guideline for primary care physiotherapy in patients with haemophilia.

A clinical practice guideline for primary care physiotherapy in patients with haemophilia.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 04, 2024

Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.

Efficacy of a 1:1 ratio VWF/FVIII concentrate in patients with von Willebrand disease.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 18, 2024

Limited value of testing for factor XIII and α2-antiplasmin deficiency in patients with a bleeding disorder of unknown cause.

Limited value of testing for factor XIII and α2-antiplasmin deficiency in patients with a bleeding disorder of unknown cause.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 18, 2024

Towards Personalized Treatment in Haemophilia: The Role of Genetic Factors in Iron and Heme Control to Identify Patients at Risk for Haemophilic Arthropathy.

Towards Personalized Treatment in Haemophilia: The Role of Genetic Factors in Iron and Heme Control to Identify Patients at Risk for Haemophilic Arthropathy.

Journal: Journal of personalized medicine

Published: December 29, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026